R
Robert A. Wise
Researcher at Johns Hopkins University School of Medicine
Publications - 533
Citations - 41683
Robert A. Wise is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: COPD & Asthma. The author has an hindex of 89, co-authored 487 publications receiving 38111 citations. Previous affiliations of Robert A. Wise include University of Texas Health Science Center at San Antonio & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Standardization of Spirometry, 1994 Update. American Thoracic Society.
R. Crapo,John L. Hankinson,Charles G. Irvin,Neil R. MacIntyre,K. Z. Voter,Robert A. Wise,Brian L. Graham,C. O'Donnell,P. Paoletti,J. Roca,G. Veigi +10 more
Journal ArticleDOI
American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
William D. Travis,Talmadge E. King,Eric D. Bateman,David A. Lynch,Frédrique Capron,Thomas V. Colby,Jean-François Cordier,Roland M. Dubois,Jeffrey R. Galvin,Philippe Grenier,David M. Hansell,Gary W. Hunninghake,Masanori Kitaichi,Nestor L. Müller,Jeffrey L. Myers,Sonoko Nagai,Andrew G. Nicholson,Ganesh Raghu,Benoit Wallaert,Christian Brambilla,Kevin K. Brown,Andrew L. Cherniaev,Ulrich Costabel,David B. Coultas,Gerald S. Davis,Maurits G. Demedts,William W. Douglas,Jim J. Egan,Anders Eklund,Leonarda M. Fabbri,Craig A. Henke,Richard Hubbard,Y. Inoue,Takateru Izumi,H. M. Jansen,Ian Johnston,Dong Soon Kim,Nasreen Khalil,Fiona R. Lake,Giuseppe Lungarella,Joseph P. Lynch,Douglas W. Mapel,Fernando J. Martinez,Richard A. Matthay,Lee S. Newman,Paul W. Noble,Ken Ohta,Dario Olivieri,Luis A. Ortiz,Venerino Poletti,Robert Rodriguez-Roisin,William N. Rom,Jay Hoon Ryu,Paulo Hilário Nascimento Saldiva,Raúl H Sansores,Marvin L. Schwarz,Moisés Selman,Cecelia M. Smith,Zhaohui Tong,Zarir F Udwadia,Dominique Valeyre,Athol U. Wells,Robert A. Wise,Antonio Xaubet,Emilio Alvarez Fernandez,Elisabeth Brambilla,Vera Luiza Capelozzi,Andrew Cherniaev,Peter Dalquen,Gerhard Dekan,Philip S. Hasleton,James C. Hogg,N. A. Jambhekar,Anna Luise A Katzenstein,Michael Koss,Osamu Matsubara,Klaus Michael Müller,F. B.J.M. Thunnissen,James A. Waldron,Wei Hua Li,Paul J. Friedman,Martin Remy-Jardin,Theresa C. McLoud +82 more
TL;DR: The Diagnostic Process Is Dynamic Clinical Evaluation Radiological Evaluation Role of Surgical Lung Biopsy Unclassifiable Interstitial Pneumonia Bronchoalveolar Lavage Fluid Evaluation Idiopathic Pulmonary Fibrosis.
Journal ArticleDOI
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.
Alfred P. Fishman,Fernando J. Martinez,Keith S. Naunheim,Steven Piantadosi,Robert A. Wise,Andrew L. Ries,Gail Weinmann,Douglas E. Wood +7 more
TL;DR: Overall, lung-volume-reduction surgery increases the chance of improved exercise capacity but does not confer a survival advantage over medical therapy, although it does yield a survival advantages for patients with both predominantly upper-lobe emphysema and low base-line exercise capacity.
Journal ArticleDOI
Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1: The Lung Health Study
Nicholas R. Anthonisen,John E. Connett,James P. Kiley,Murray D. Altose,William C. Bailey,A. Sonia Buist,William A. Conway,Paul L. Enright,Richard E. Kanner,Peggy O'Hara,Gregory R. Owens,Paul D. Scanlon,Donald P. Tashkin,Robert A. Wise,M. D. Altose,Alfred F Connors,Susan Redline,C. Deitz,R. F. Rakos,W. A. Conway,A. Dehorn,J. C. Ward,C. S. Hoppe Ryan,R. L. Jentons,J. A. Reddick,C. Sawicki,R. A. Wise,S. Permutt,Cynthia S. Rand,P. D. Scanlon,L. J. Davis,R. D. Hurt,R. D. Miller,D. E. Williams,G. M. Caron,G. G. Lauger,S. M. Toogood,A. S. Buist,W. M. Bjornson,L. R. Johnson,W. C. Bailey,C. M. Brooks,J. J. Dolce,D. M. Higgins,M. A. Johnson,C. D. Lorish,B. A. Martin,D. P. Tashkin,A. H. Coulson,H. Gong,Philip Harber,V. C. Roth,M. Roth,Mitchell A. Nides,M. S. Simmons,I. Zuniga,N. R. Anthonisen,J. Manfreda,R. P. Murray,S. C. Rempel Rossum,J. M. Stoyko,J. E. Connett,M. O. Kjelsberg,M. K. Cowles,D. A. Durkin,P. L. Enright,K. J. Kurnow,W. W. Lee,P. G. Lindgren,S. J. Mongin,P. O'hara,H. T. Voelker,Lance A. Waller,G. R. Owens,R. M. Rogers,J. J. Johnston,F. P. Pope,F. M. Vitale,R. E. Kanner,M. A. Rigdon,K. C. Benton,P. M. Grant,M. Becklake,Benjamin Burrows,P. Cleary,P. Kimbel,L. Nett,J. K. Ockene,R. M. Senior,G. L. Snider,W. Spitzer,O. D. Williams,S. S. Hurd,J. P. Kiley,M. C. Ayres,S. M. Ayres,R. E. Hyatt,Benjamin A. Mason +97 more
TL;DR: An aggressive smoking intervention program significantly reduces the age-related decline in FEV 1 in middle-aged smokers with mild airways obstruction and use of an inhaled anticholinergic bronchodilator results in a relatively small improvement inFEV 1 that appears to be reversed after the drug is discontinued.
Journal ArticleDOI
Long-term effects of budesonide or nedocromil in children with asthma.
Stanley J. Szefler,Scott T. Weiss,James Tonascia,N. Franklin Adkinson,Bruce G. Bender,Reuben M. Cherniack,Michele Donithan,H William Kelly,J. Reisman,Gail G. Shapiro,Alice L. Sternberg,R.C. Strunk,Virginia S. Taggart,Mark L. Van Natta,Robert A. Wise,Margaret Wu,Robert S. Zeiger +16 more
TL;DR: In children with mild-to-moderate asthma, neither budesonide nor nedocromil is better than placebo in terms of lung function, but inhaled budesonides improves airway responsiveness and provides better control of asthma than placebo or nedOCromil.